« Return to Article Summary

Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver As Risk Factors for Type 2 Diabetes

Article Options

Go To PubMed Read Full Abstract, Find Related Articles, and more ... PubMed Link
Go To Abstract Diabetes Care - Read Full Abstract, Read Full Text Article, Access Prior Issues ... Publisher Link
Print Article Summary
Related Articles MDlinx Article Summaries on Similar Topics from Clinician-Valued Journals

1 On-statin resistin, leptin, and risk of recurrent coronary events after hospitalization for an acute coronary syndrome (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 study) The American Journal of Cardiology, June 29, 2015

2 Olive oil consumption and risk of type 2 diabetes in US women American Journal of Clinical Nutrition, July 10, 2015

3 Metformin as initial oral therapy in type 2 diabetes JAMA, July 6, 2015    Evidence Based Medicine

4 Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG Trial Diabetes Care, July 17, 2015

5 Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: A critical review Acta Psychiatrica Scandinavica, July 15, 2015    Review Article

6 Health effects of intermittent fasting: hormesis or harm? A systematic review American Journal of Clinical Nutrition, July 3, 2015    Evidence Based Medicine    Review Article

7 Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial Drug Design, Development and Therapy, July 7, 2015

8 Association of cardiometabolic multimorbidity with mortality JAMA, July 8, 2015    Evidence Based Medicine

9 Concurrent obesity, diabetes, and steatosis increase risk of advanced fibrosis among HCV patients: A systematic review Digestive Diseases and Sciences, July 9, 2015    Review Article

10 A randomized, controlled trial of 3.0 mg of liraglutide in weight management New England Journal of Medicine, July 3, 2015    Evidence Based Medicine